lomefloxacin has been researched along with Cirrhosis, Liver in 1 studies
lomefloxacin: structure given in first source
lomefloxacin : A fluoroquinolone antibiotic, used (generally as the hydrochloride salt) to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery.
| Excerpt | Relevance | Reference |
|---|---|---|
| "6 hours, and the mean elimination half-life (t1/2) was 9." | 1.28 | Pharmacokinetics of lomefloxacin in patients with cirrhosis. ( Benhamou, JP; Gaudin, C; Lebrec, D, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lebrec, D | 1 |
| Gaudin, C | 1 |
| Benhamou, JP | 1 |
1 other study available for lomefloxacin and Cirrhosis, Liver
| Article | Year |
|---|---|
Pharmacokinetics of lomefloxacin in patients with cirrhosis.
Topics: Adult; Anti-Infective Agents; Chromatography, High Pressure Liquid; Female; Fluoroquinolones; Humans | 1992 |